
News|Articles|September 15, 2019
Why Pharmacopoeia Compliance Is Difficult–An End-to-End Compendial Framework (PDF)
Author(s)J. Mark Wiggins, Joseph A. Albanese
This article provides an end-to-end compendial framework to understand why compliance with pharmacopoeia standards is challenging.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
EMA Calls New EU Pharma Legislation Most Significant in Two Decades
2
FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025
3
FDA’s CNPV Pilot Gives First Approval to Antibiotic for Pneumonia and Sinusitis
4
European Parliament Revamps Pharmaceutical Policy Framework
5





